The Annual General Meeting for this year took place on 18 November 2025 at Kiangsu Chekiang and Shanghai Residents (HK). Council members and attendees enjoyed an engaging evening. Please <click here> for the meeting highlights.

The HKIA Awards Presentation Ceremony was held on 18 October 2025 with the 13th Hong Kong Allergy Convention. For full list of awardees and their citations, please <click here> to view.

• Review of monoclonal antibody therapies in asthma and allergic diseases - a new paradigm for precision medicine
  <click here for the news>

• Nightmares, hallucinations, depression: side effects of asthma drug prescribed to children for minor coughs and hay fever
  <click here for the news>

• 2020 American Academy of Allergy, Asthma & Immunology: Characteristics of Chinese fish-allergic patients: Findings from double-blind placebo-controlled food challenges
  <click here for the news>

Click for more details

It is with great pleasure that we announce our Institute's 30-year celebratory event, the Hong Kong International Allergy Summit (HKIAS). Partnering with Fondaizone Menarini, the HKIAS will take place on November 28 to 29, 2026, at the HKUMed campus in Hong Kong.

More than 20 internationally renowned faculty members from all continents — Australasia, Africa, the Americas, Asia, and Europe — will meet to celebrate three decades of commitment to furthering allergy excellence at the largest allergy summit ever held in our region. Please click here to view the event programme and learn more about the event.

This prestigious event features state-of-the-art updates, hot topic debates, and the sharing of ground-breaking clinical research. Furthermore, world allergy leaders will be discussing and drafting new global recommendations. As a registrant, you can be part of this historic moment by taking part in the discussions and witnessing these new roadmaps firsthand. Participants will benefit from a comprehensive range of allergy sessions covering airway allergy, allergy diagnostics, anaphylaxis, biologic therapies, drug allergy, immunotherapy, and skin allergy.

To make this remarkable event accessible, the summit is entirely free of charge for all registrants, and CME/CNE will be available. Moreover, this event is completely independent of any commercial talks and industry-sponsored seminars, allowing our speakers to discuss openly without holding back and ensuring complete freedom of scientific engagement free from any bias.

Slots are strictly limited on a first-come, first-served basis. If you wish to meet face-to-face with global giants at this first-of-its-kind allergy summit, please register your slot here.

Please click HERE for the event highlights.

HKIA presented a Dinner Symposium on "Assessment and Management for Secondary Immunodeficiency in Adults: An Immunologist's Perspective" on 26 May 2026 (Tuesday) at Cordis Hong Kong Hotel.

The evening symposium featured expert insights and practical demonstrations from leading clinicians in immunology. Renowned speakers Prof. Suran Fernando (Australia), Dr. Philip H. Li (Hong Kong), and Ms. Candy Chan (Hong Kong) shared valuable perspectives on the assessment and management of secondary immunodeficiency in adults, offering both clinical expertise and real-world applications.

Please click HERE for the event highlights.

HKIA and HKUMed co-hosted a seminar entitled "Trends in Anaphylaxis & Multiplex Testing".

This hybrid session reviewed current and emerging trends in the diagnosis and management of anaphylaxis, with a focus on component-resolved and multiplex IgE diagnostics to support personalized, evidence-based clinical practice. Discussions led by Dr. Philip Li, Dr. Eszter Sarzinszky, and Dr. Marco HK Ho highlighted evolving epidemiological patterns in Hong Kong and beyond, as well as strategies to enhance clinical pathways, improve risk assessment, and optimize patient outcomes.

Please click HERE for the event highlights.

The MASTER Certificate Course on "Multidisciplinary Allergy Services: Treatment, Education and Research", co-hosted by the Hong Kong Institute of Allergy and the Department of Medicine, School of Clinical Medicine, HKUMed, was successfully held on 7 March 2026, bringing together physicians and allied health professionals committed to advancing allergy care in Hong Kong.

Against the backdrop of a rapidly growing allergy disease burden and an ongoing shortage of specialist services, the course addressed an urgent local need by focusing on capacity building through multidisciplinary collaboration. Drawing on Hong Kong's successful experience in joint allergy clinics, the programme highlighted how coordinated care involving physicians, nurses and pharmacists can enhance service delivery and patient outcomes.

Participants benefited from a comprehensive programme combining didactic lectures and hands-on practical sessions. Experienced physicians and allied health leaders shared practical insights into the establishment and operation of multidisciplinary clinics across key allergy domains, including drug, food, paediatric, skin and airway allergy. Real-world case discussions and interactive sessions enabled participants to exchange experiences and translate evidence-based principles into clinical practice. The course also fostered meaningful cross-disciplinary networking, laying the groundwork for future collaboration and supporting the development of new and expanded allergy services across Hong Kong. Feedback from participants highlighted the course's relevance, practicality and timely focus on multidisciplinary service models.

Please click HERE for the event highlights.

The collaboration between HKIA, HKUMed, and HKSH co-hosted a seminar on "Drug Allergy: Clinical Practices Across the Pacific" on 22 January 2026 in Hong Kong.

This seminar brought together leading experts in the field of drug allergy to compare contemporary approaches to diagnosis and management, with a particular focus on in vitro testing. The seminar also highlighted state-of-the-art methodologies, regional differences in clinical practice, and emerging innovations in allergy diagnostics. Through open dialogue, industry experts Prof. Elizabeth Phillips from Vanderbilt University Medical Center, USA and Dr. Elaine Au from Queen Mary Hospital, Hong Kong shared real-world experience. They discussed the strengths and limitations of current testing strategies and explored opportunities for harmonization and collaboration in advancing safe, evidence-based care for patients with history of severe drug allergies.

Please click HERE for the event highlights.